| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-17 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-15 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-15 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-15 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-14 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-14 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-14 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-13 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-13 |